11:11:51 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

2022-10-20 Kvartalsrapport 2022-Q3
2022-07-15 Kvartalsrapport 2022-Q2
2022-04-29 Ordinarie utdelning GHP 0.00 SEK
2022-04-28 Årsstämma 2022
2022-04-27 Kvartalsrapport 2022-Q1
2022-02-23 Bokslutskommuniké 2021
2021-10-22 Kvartalsrapport 2021-Q3
2021-07-13 Kvartalsrapport 2021-Q2
2021-04-30 Ordinarie utdelning GHP 0.50 SEK
2021-04-29 Årsstämma 2021
2021-04-22 Kvartalsrapport 2021-Q1
2021-02-23 Bokslutskommuniké 2020
2020-10-22 Kvartalsrapport 2020-Q3
2020-07-10 Kvartalsrapport 2020-Q2
2020-04-24 Ordinarie utdelning GHP 0.00 SEK
2020-04-23 Årsstämma 2020
2020-04-22 Kvartalsrapport 2020-Q1
2020-02-19 Bokslutskommuniké 2019
2019-10-24 Kvartalsrapport 2019-Q3
2019-07-12 Kvartalsrapport 2019-Q2
2019-04-25 Ordinarie utdelning GHP 0.30 SEK
2019-04-24 Årsstämma 2019
2019-04-23 Kvartalsrapport 2019-Q1
2019-02-20 Bokslutskommuniké 2018
2018-10-25 Kvartalsrapport 2018-Q3
2018-07-13 Kvartalsrapport 2018-Q2
2018-04-26 Ordinarie utdelning GHP 0.00 SEK
2018-04-25 Årsstämma 2018
2018-04-24 Kvartalsrapport 2018-Q1
2018-02-21 Bokslutskommuniké 2017
2017-10-26 Kvartalsrapport 2017-Q3
2017-07-18 Kvartalsrapport 2017-Q2
2017-04-27 Ordinarie utdelning GHP 0.30 SEK
2017-04-26 Årsstämma 2017
2017-04-25 Kvartalsrapport 2017-Q1
2017-02-22 Bokslutskommuniké 2016
2016-10-28 Kvartalsrapport 2016-Q3
2016-07-15 Kvartalsrapport 2016-Q2
2016-04-28 Ordinarie utdelning GHP 0.15 SEK
2016-04-27 Årsstämma 2016
2016-04-26 Kvartalsrapport 2016-Q1
2016-02-24 Bokslutskommuniké 2015
2015-10-29 Kvartalsrapport 2015-Q3
2015-07-14 Kvartalsrapport 2015-Q2
2015-04-30 Ordinarie utdelning GHP 0.13 SEK
2015-04-29 Årsstämma 2015
2015-04-28 Kvartalsrapport 2015-Q1
2015-02-19 Bokslutskommuniké 2014
2014-10-31 Analytiker möte 2014
2014-10-31 Kvartalsrapport 2014-Q3
2014-07-15 Kvartalsrapport 2014-Q2
2014-04-30 Ordinarie utdelning GHP 0.00 SEK
2014-04-29 Årsstämma 2014
2014-04-28 Kvartalsrapport 2014-Q1
2014-02-20 Bokslutskommuniké 2013
2013-10-30 Kvartalsrapport 2013-Q3
2013-10-30 Analytiker möte 2013
2013-07-15 Kvartalsrapport 2013-Q2
2013-05-03 Ordinarie utdelning GHP 0.00 SEK
2013-05-02 Årsstämma 2013
2013-04-26 Kvartalsrapport 2013-Q1
2013-03-13 15-7 2013
2013-02-26 Bokslutskommuniké 2012
2012-11-28 Extra Bolagsstämma 2012
2012-11-02 Analytiker möte 2012
2012-11-02 Kvartalsrapport 2012-Q3
2012-07-17 Kvartalsrapport 2012-Q2
2012-05-04 Ordinarie utdelning GHP 0.00 SEK
2012-05-03 Årsstämma 2012
2012-04-27 Kvartalsrapport 2012-Q1
2012-02-24 Bokslutskommuniké 2011
2011-11-01 Kvartalsrapport 2011-Q3
2011-07-19 Kvartalsrapport 2011-Q2
2011-05-05 Ordinarie utdelning GHP 0.00 SEK
2011-05-04 Årsstämma 2011
2011-04-28 Kvartalsrapport 2011-Q1
2011-02-23 Bokslutskommuniké 2010
2010-11-02 Kvartalsrapport 2010-Q3
2010-07-19 Kvartalsrapport 2010-Q2
2010-04-30 Ordinarie utdelning GHP 0.00 SEK
2010-04-29 Årsstämma 2010
2010-04-26 Kvartalsrapport 2010-Q1
2010-02-20 Bokslutskommuniké 2009
2009-11-03 Kvartalsrapport 2009-Q3
2009-07-20 Kvartalsrapport 2009-Q2
2009-04-30 Ordinarie utdelning GHP 0.00 SEK
2009-04-29 Kvartalsrapport 2009-Q1
2009-04-29 Årsstämma 1

Beskrivning

LandSverige
ListaSmall Cap Stockholm
SektorHälsovård
IndustriVård & Omsorg
GHP Specialty Care är verksamma inom vård och omsorg. Idag bedriver bolaget specialistkliniker inom ryggkirurgi/ryggvård, specialisttandvård, fetmakirurgi och metabola sjukdomar, ortopedi samt arytmi. Verksamheten är koncentrerad till den nordiska marknaden och bolaget är verksamma inom ett flertal globala regioner. GHP Specialty Care etablerades 2006 och har sitt huvudkontor i Göteborg.
2020-04-22 08:00:00
  • The results are GHP’s best quarterly results so far
  • Strong organic growth
  • All three segments improve their results in the quarter
  • GHP adapts to new assignments and changed conditions during the corona crisis

First quarter 2020

  • Sales revenues increased to SEK 383.1 million (330.4)
  • Organic growth amounted to 12.3 percent (17.4)
  • EBITDA increased to SEK 54.2 million (42.2)
  • EBITDA margin increased to 14.2 percent (12.8)
  • EBIT amounted to SEK 30.0 million (21.4)
  • EBIT margin amounted to 7.8 percent (6.5)
  • Result after tax amounted to SEK 23.0 million (15.1)
  • Result per share amounted to SEK 0.30 (0.18)

CEO’s comments
The first quarter of 2020 was unique from several perspectives. We have never before gone into a new year better positioned to efficiently deliver high quality health care. This can also be seen in our financial results, where we have high organic growth in the quarter and have our best quarterly results so far. However, what makes the quarter even more unique and challenging is the ongoing spread of the corona virus. As a health care company, we are both impacted by the situation and we can help to impact the situation. One of GHP’s key concepts is that we will create societal benefit and over the years this has permeated our way of working, both in the Nordic market and internationally. In these times, however, the importance of being able to contribute to societal benefit becomes clearer than ever.
 
GHP has a strong base to stand on, with smoothly functioning and efficient clinics, but when conditions change quickly it becomes more difficult to maintain efficiency. This means that we are expecting a considerable negative impact on our financial results in the coming quarters. At the same time, we feel secure in the knowledge that our decentralised way of working means that we can adapt quicker and will help us to return to a normal situation when the most critical corona period is over.
 
In the Nordic Region we continue to grow at the same time as we are improving our results. Most of our clinics noticed a slowing down of their business at the end of the quarter, particularly as we have chosen not to treat risk groups who do not have an immediate health care need. The situation we now find ourselves in means that both public and private actors face new, time-critical challenges, which sometimes means that the necessary conditions are not in place. We therefore have a close dialogue with both existing clients and new clients on this topic.

In the Nordic Region our basic premise is that we can best help by the regions passing on priority care to us that they themselves do not currently have the time for. For example, we have new assignments in the field of urological cancer operations, and we have also started up a geriatric ward. These measures release capacity at the emergency hospitals for corona patients at the same time as we can make use of our fixed costs (including personnel costs). We have also hired out key personnel to the Stockholm region to help with ICU care. All in all, we have in many respects been able to maintain a reasonable level of business operations, but the highly fluid situation makes it difficult to be efficient. Furthermore, we have furloughed, laid off, reduced salaries and terminated consultants. In Denmark, after a couple of weeks of no surgical activities, we have now obtained permission to open up our activities gain.
 
In International we also started the year with high growth and improved results. A contributory factor here is our management contract in Kuwait which was started last summer. Since then we have worked on gradually scaling up the hospital. The restrictions that exist in the country due to the coronavirus make it more challenging for us to run these business operations and this may impact earnings, but we look forward to holding the official inauguration ceremony for the hospital as soon as possible.
 
The hospitals that GHP runs in the UAE are playing an important role in the management of corona in Ajman. The personnel have done a fantastic job preparing the hospitals and taking care of all these new patients. We are delighted to see that this is appreciated by our client and by society in Ajman. 
 
In Vårdsamverkan we have for a long time developed digital solutions for patients, customers and care providers. We have been able to make use of these solutions in these times as it may be an advantage to reduce the number of physical appointments, which is a tool for reducing the spreading of the disease. We have therefore taken the opportunity of introducing digital appointments at almost all our clinics.
 
Even if the year has started well from a financial perspective, what pleases me most when I look back on the first quarter is the drive that exists in all our businesses regarding rapidly adapting to new conditions. Results the two coming quarters will be impacted negatively and there will be challenges in our businesses, but we expect that when the crisis has faded we will see very strong demand and be able to revert to good results.